Should I buy or start a veterinary practice?

Buying an existing practice gives you positive cash flow from day 1 and a documented client base, but costs $500K–$1.5M upfront. Starting de-novo avoids that acquisition cost but requires 18–24 months to break even. If you have less than 24 months of personal runway or need immediate income to service student loans, buying usually wins in the short run. If you have time, capital, and a clear underserved market, de-novo can produce higher 5-year equity with wider upside.

How much does it cost to buy a veterinary practice?

Most vet practice acquisitions are priced at 70–95% of annual collections, or 4–6× normalized EBITDA for private buyers. A practice generating $1.2M in annual collections typically costs $840K–$1.14M. You need 10% down if goodwill is $500K or under, or 25% down if goodwill exceeds $500K, with the balance financed by an SBA 7(a) loan at up to Prime + 2.75% (max 9.50% in 2026).

How much does it cost to start a veterinary practice from scratch?

Starting a general small-animal clinic typically costs $350K–$900K (equipment, leasehold build-out, and 6–12 months of working capital). A specialty or emergency practice can run $600K–$1.5M+. SBA 7(a) startup loans require 15–20% down because underwriting is projection-based rather than backed by existing cash flow. Expect to operate at or near breakeven for the first 12–24 months.

What SBA loan do I use to buy or start a vet practice?

Both paths use SBA 7(a) loans. Key 2026 terms: 10-year repayment, rate capped at Prime + 2.75% (9.50% max with WSJ Prime at 6.75%). For acquisitions with goodwill ≤$500K, down payment is 10%; above that threshold, 25% is required. A seller note can count as part of your equity injection. Specialized vet lenders with SBA experience include Live Oak Bank, US Bank, and Captec Financial.

Can I buy a vet practice if I have student loans?

Yes. Student loan payments count toward your SBA debt-service ratio, but if you are on IBR or PSLF the underwritten monthly payment is your actual IBR payment — not the 10-year standard amount. At $200K in debt on IBR, that might be $350–$600/month rather than $2,200, which meaningfully improves your debt coverage. A vet-experienced SBA lender can structure the deal around your full debt picture. Avoid refinancing federal loans to private before you close — it may eliminate PSLF eligibility and change your underwriting profile.

Is joining a corporate vet group a better financial move than buying a practice?

The corporate path (Mars, NVA, MVP, VCA) gives immediate W-2 income with no down payment or SBA debt, which can be the right call if you have heavy student debt and need cash flow to pay it down. The trade-off: no equity build, no ownership upside at a corporate exit, and no practice-as-asset in retirement planning. Practice owners who sell to a corporate group at 8–14× EBITDA typically walk away with $1M–$5M+ depending on practice size — an outcome unavailable to associates. Use our Corporate Offer vs. Stay Solo Calculator to model the NPV comparison for your specific numbers.

What is the break-even timeline for a de-novo veterinary practice?

Most de-novo small-animal clinics break even on a monthly cash-flow basis between months 12 and 24. Profitability depends heavily on location demographics, competition, your starting client volume, and whether you are using a walk-in or appointment model. High-growth suburban markets with limited competition break even faster; saturated urban markets or specialty de-novos may take 24–36 months. You should model at least 18 months of personal living expenses and operating losses into your startup capital requirement.

Should You Buy or Start a Veterinary Practice?

The buy-vs-build decision shapes the next 10–15 years of your financial life. The financial profile of each path is different enough that they're almost separate businesses — one that pays you immediately, one that may pay you much more eventually.

	Buy existing	Start de-novo
Upfront cost	$500K–$1.5M (70–95% of collections)	$350K–$900K (equipment, build-out, working capital)
Financing	SBA 7(a) practice acquisition loan, 10-year	SBA 7(a) startup loan + working capital line
Down payment	10% (goodwill ≤$500K) or 25% (goodwill >$500K)	15–20% (projection-based underwriting)
Year 1 cash flow	Positive from day 1 (existing client base)	Negative for 12–24 months
Growth ceiling	Modest unless you expand services or add associates	Higher — you build the culture, brand, and systems
Risk profile	Lower (buying documented history)	Higher (buying a location + hypothesis)
Corporate sale multiple	Same 8–14× EBITDA at exit	Same 8–14× EBITDA at exit (if you build it there)

Why buying usually wins in Year 1

A practice doing $1.2M collections, EBITDA $360K, purchased at $900K with 10% down ($90K cash). SBA 7(a) 10-year at 9.0% = $9,200/month debt service ($110K/yr). Year-1 net after debt and your owner salary: ~$250K. A de-novo rarely matches that before month 18–24.

That immediate cash flow matters if you have student loans, a family, or any financial obligations that need a paycheck from day one.

Why de-novo often wins Year 5+

A well-run startup with your systems, brand, and patient relationships grows more aggressively. Five years in, a successful de-novo often has equivalent or higher EBITDA and has bypassed the $500K–$1.5M acquisition cost entirely. You also avoid the risk of paying for someone else's hidden problems — staff turnover, deferred maintenance, equipment with two years of life left.

Buy when…

You need positive cash flow immediately
You have 10–25% down (or a seller note)
A well-run practice in your target area is available
You can't sustain 18–24 months of negative cash flow
You want to skip the ramp-up risk entirely

Start de-novo when…

You have 24–36 months of personal runway
You have a clear underserved location
You want full operational control from the start
Available practices in your market are overpriced or poorly run
You're in a high-growth suburban area where a corporate hasn't planted yet

Run the numbers on your specific deal

Use our Practice Acquisition ROI Calculator to compare year-1 and 10-year wealth for your exact scenario — or get a fee-only advisor to model it with you.

Get matched with a vet financial advisor →

SBA financing: what each path looks like

Both paths typically use SBA 7(a) loans. The differences matter significantly for underwriting and cash flow.

	Acquisition (buy)	Startup (de-novo)
Loan size range	$400K–$1.5M	$300K–$900K
Rate (2026, >$350K)	Prime + up to 2.75% = 9.50% max	Same rate structure
Loan term	10 years	10 years
Down payment	10% if goodwill ≤$500K; 25% if >$500K	15–20% (no existing cash flow to underwrite)
What lenders look at	Practice historical cash flow (DSCR ≥1.25x)	Your business projections + location + your resume
Specialized lenders	Live Oak Bank, US Bank, Captec Financial (all vet-experienced)

The down payment rule for acquisitions has a threshold: if the practice's goodwill (intangible value) exceeds $500K, SBA requires 25% down rather than 10%. At a $1.2M purchase price, that's the difference between $120K and $300K in cash at close. A seller note can count as part of your equity injection in some deals — your lender and an advisor can help you structure this.

5-year wealth comparison: a realistic scenario

Both scenarios assume the same DVM, same market, starting at year 0.

Year	Buy existing ($900K practice, $90K down)	De-novo ($600K startup, $90K down + $30K working capital)
Year 1 net income	~$250K (after $110K debt service)	−$50K to +$50K (building client base)
Year 2 net income	~$270K (modest growth)	$100K–$180K (accelerating)
Year 3 net income	~$290K	$200K–$270K
Year 5 EBITDA	$380K–$420K	$350K–$500K+ (wider range)
Year 5 equity (at 5× EBITDA)	$1.9M–$2.1M (minus ~$680K remaining loan)	$1.75M–$2.5M (minus ~$450K remaining loan)
Year 5 net equity	~$1.25M–$1.45M	~$1.3M–$2.0M (wider range; higher upside, higher risk)

Key insight: On average, the 5-year net equity ends up similar. The difference is path: buying gives you a smoother, more predictable line; de-novo gives you higher variance — potentially better, potentially worse. Your risk tolerance and cash reserves determine which is right for you.

The corporate offer as a third path

Before you decide to buy or build, consider whether joining a corporate-owned practice makes more financial sense right now. Mars, NVA, MVP, and VCA all hire associate DVMs at competitive salaries with benefits. The upside: no $90K–$300K down payment, no SBA loan, positive cash flow from day one, and you can aggressively pay down student loans or invest during your associate years.

The downside: no equity build, no ownership upside at a corporate exit (unless you're in a roll-equity deal), and no practice-as-asset in retirement planning. The right answer depends heavily on your debt load, timeline to partnership, and local deal availability.

Use our Corporate Offer vs. Stay Solo Calculator to model the NPV comparison over 10+ years.

If you're buying: due diligence checklist

Don't rely on the seller's financials at face value. Before you sign an LOI, verify:

Normalized EBITDA: Add back excessive owner compensation, personal vehicles, family payroll — the real earnings power may be quite different from the P&L. See our full due diligence guide.
Collections trend: Is revenue growing, flat, or declining? A shrinking practice at 90% of collections is a worse deal than a growing one at 80%.
Staff retention risk: If the departing owner is the practice identity, assume you lose 15–30% of clients in the transition. Model that scenario before you sign.
Equipment age: Aging diagnostic equipment (DR, dental, ultrasound, anesthesia) means capex in years 1–3. Get an independent equipment assessment.
Real estate: Are you buying the building too, leasing from the seller, or leasing from a third party? The lease terms can make or break the deal. See our real estate ownership guide.
Corporate consolidator interest: Has the practice already been approached by Mars/NVA/MVP? That could be an upside signal — or a warning sign that the seller is taking their best private-market price before the corporate offers expire.

How a vet financial advisor helps with this decision

A generalist financial advisor won't know the difference between a 5× and 10× EBITDA deal, how to structure a seller note as SBA equity injection, or whether a specific practice's cash flow can support the debt service you're about to take on.

A vet-specialist fee-only advisor can:

Run an independent valuation model on the practice you're considering buying (cross-check the asking price against EBITDA multiples and collections benchmarks)
Model year 1–5 net income, debt service coverage, and retirement contribution capacity under both purchase and de-novo scenarios
Advise on deal structure: seller note, SBA terms, earnout provisions, and whether a corporate offer at the same moment changes the math
Set up the right entity structure (PLLC or S-corp) before close to maximize tax efficiency from day one
Integrate the practice acquisition into a broader financial plan — student loans, disability insurance, cash balance plan, Solo 401(k) timing

Sources

SBA rates based on WSJ Prime Rate 6.75% as of March 2026. Practice valuation ranges reflect 2025–2026 private-market transactions. Verify current rates with lenders before applying.

Get your specific deal modeled

A fee-only advisor will run the numbers on your actual purchase or startup scenario — including debt service coverage, entity structure, and retirement plan integration. Free match.